SCHEMBL7667889

SCHEMBL7667889

CC(C)(C)OC(=O)CNS(=O)(=O)c1ccc(NC(=O)Cc2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 1/20 0.57
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA5A P35218 1/20 0.55
CA7 P43166 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
CA5B Q9Y2D0 1/20 0.55
TSHR P16473 1/20 0.52
LMNA P02545 4/20 0.52
ALDH1A1 P00352 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
RORC P51449 2/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
RAB9A P51151 1/20 0.50
F2 P00734 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7669640 0.86 GHSR (0.53) CA12CA1CA2CA9TSHR
SCHEMBL7582747 0.84 LMNA (0.65) PRMT1CA12CA1CA2CA9
SCHEMBL4828109 0.83 PRMT1 (0.69) PRMT1CA12CA1CA2CA5A
SCHEMBL28588397 0.83 ALDH1A1 (0.51) CA12CA1CA7CA14ALDH1A1
SCHEMBL7671582 0.82 ALDH1A1 (0.50) TSHRLMNAALDH1A1MEN1KMT2A
SCHEMBL7663139 0.82 POLB (0.62) CA12CA1CA2CA9LMNA
SCHEMBL7667742 0.81 ALDH1A1 (0.50) CA12CA1CA7CA14LMNA
SCHEMBL7663740 0.81 ALDH1A1 (0.65) PRMT1CA12CA1CA9LMNA
SCHEMBL7666345 0.80 LMNA (0.57) PRMT1LMNAALDH1A1SMN1; SMN2MEN1
SCHEMBL7667729 0.80 ALDH1A1 (0.61) LMNAALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed